tiprankstipranks
Agios Pharma (DE:8AP)
FRANKFURT:8AP
Holding DE:8AP?
Track your performance easily

Agios Pharma (8AP) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Agios Pharma’s (8AP) Moving Averages Convergence Divergence (MACD) indicator is -3.48, suggesting Agios Pharma is a Buy.
Agios Pharma’s (8AP) 20-Day exponential moving average is 44.58, while Agios Pharma’s (8AP) share price is €34.2, making it a Sell.
Agios Pharma’s (8AP) 50-Day exponential moving average is 45.68, while Agios Pharma’s (8AP) share price is €34.2, making it a Sell.

Agios Pharma (8AP) Pivot Points

Dec 22, 2024, 07:51 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
37.20
37.20
37.20
37.20
37.20
37.20
37.20
Fibonacci
37.20
37.20
37.20
37.20
37.20
37.20
37.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Agios Pharma (8AP) Moving Averages

Dec 22, 2024, 07:51 AM
Period
Simple
Exponential
MA5
37.60Sell
37.61Sell
MA10
41.20Sell
40.89Sell
MA20
48.08Sell
44.58Sell
MA50
46.42Sell
45.68Sell
MA100
43.21Sell
43.62Sell
MA200
38.94Sell
38.42Sell
Agios Pharma’s (8AP) 10-Day exponential moving average is 40.89, while Agios Pharma’s (8AP) share price is €34.2, making it a Sell.
Agios Pharma’s (8AP) 100-Day exponential moving average is 43.62, while Agios Pharma’s (8AP) share price is €34.2, making it a Sell.
Agios Pharma’s (8AP) stock price is €34.2 and Agios Pharma’s (8AP) 50-day simple moving average is 46.42, creating a Sell signal.
Agios Pharma’s (8AP) stock price is €34.2 and Agios Pharma’s (8AP) 100-day simple moving average is 43.21, creating a Sell signal.
Agios Pharma’s (8AP) stock price is €34.2 and Agios Pharma’s (8AP) 200-day simple moving average is 38.94, creating a Sell signal.

Agios Pharma (8AP) Technical Indicators

Dec 22, 2024, 07:51 AM
Name
Value
Implied Action
RSI (14)
29.44
Buy
STOCH (9,6)
6.73
Buy
STOCHRSI (14)
6.73
Buy
MACD (12,26)
-3.48
Buy
ADX (14)
33.77
Neutral
Williams %R
-100.00
Buy
CCI (14)
-117.57
Buy
ATR (14)
2.12
-
Ultimate Oscillator
23.22
Sell
ROC
-38.38
Sell
Agios Pharma’s (8AP) Relative Strength Index (RSI) is 29.44, creating a Buy signal.
Agios Pharma’s (8AP) Trend Strength Indicator (ADX) is 33.77, creating a Neutral signal.
Agios Pharma’s (8AP) Commodity Channel Index (CCI) is -117.57, creating a Buy signal.
Agios Pharma’s (8AP) Price Rate of Change (ROC) is -38.38, creating a Sell signal.

FAQ

Is 8AP a Buy, Hold, or Sell?
Based on 8AP’s technical indicators, 8AP is a Sell.
    What is 8AP’s RSI (14)?
    8AP’s RSI (14) is 29.44, which suggests 8AP is a Buy.
      What is 8AP’s MACD?
      8AP’s MACD is -3.48, which suggests 8AP is a Buy.
        What is 8AP’s 5-day moving average?
        8AP’s 5-day moving average is 37.60, which suggests 8AP is a Sell.
          What is 8AP’s 20-day moving average?
          8AP 20-day moving average is 48.08, which suggests 8AP is a Sell.
            What is 8AP’s 50-day moving average?
            8AP’s 50-day moving average is 46.42, which suggests 8AP is a Sell.
              What is 8AP’s 200-day moving average?
              8AP’s 200-day moving average is 38.94, which suggests 8AP is a Sell.
                What is 8AP’s Williams % R (14)?
                8AP’s Williams % R (14) is -100.00, which suggests 8AP is a Buy.
                  What is 8AP’s CCI (14)?
                  8AP’s CCI (14) is -117.57, which suggests 8AP is a Buy.
                    What is the share price of Agios Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis